PANTOPRAZOLE SODIUM Delayed Release is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by New Horizon Rx Group, Llc. The primary component is Pantoprazole Sodium.
Product ID | 58517-420_3488e3d7-1285-4002-b351-15f59623a2eb |
NDC | 58517-420 |
Product Type | Human Prescription Drug |
Proprietary Name | PANTOPRAZOLE SODIUM Delayed Release |
Generic Name | Pantoprazole Sodium |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2013-08-25 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA077058 |
Labeler Name | New Horizon Rx Group, LLC |
Substance Name | PANTOPRAZOLE SODIUM |
Active Ingredient Strength | 40 mg/1 |
Pharm Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2013-08-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA077058 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-08-25 |
Inactivation Date | 2019-11-27 |
Ingredient | Strength |
---|---|
PANTOPRAZOLE SODIUM | 40 mg/1 |
SPL SET ID: | 1e4edc4d-fa80-4afc-9864-59009764601f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
51655-500 | Pantoprazole Sodium Delayed Release | Pantoprazole Sodium Delayed Release |
58517-420 | PANTOPRAZOLE SODIUM Delayed Release | PANTOPRAZOLE SODIUM Delayed Release |
0093-0011 | Pantoprazole Sodium | Pantoprazole Sodium |
0093-0012 | Pantoprazole Sodium | Pantoprazole Sodium |
0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium |
0008-0841 | Protonix | PANTOPRAZOLE SODIUM |
0008-0843 | Protonix | PANTOPRAZOLE SODIUM |
0008-0844 | Protonix | PANTOPRAZOLE SODIUM |
0008-0923 | Protonix | PANTOPRAZOLE SODIUM |
0008-0941 | Protonix | pantoprazole sodium |
0008-2001 | Protonix | PANTOPRAZOLE SODIUM |
0008-4001 | Protonix | PANTOPRAZOLE SODIUM |